The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) recently held its 22nd Annual International Meeting in Boston, MA. The conference drew 4,195 attendees representing 76 countries and all sectors of the healthcare market. This diverse audience of researchers, payers, health technology assessors, patient representatives, and others convened to discuss how the recent upheavals in the political landscape will affect how we finance and deliver healthcare in this country and around the world.
The conference focused on the very timely theme, “Evidence and Value in a Time of Social and Policy Change.” The scientific sessions covered a wide variety of compelling topics in health economics and outcomes research, including real-world evidence, health policy, patient engagement, 21st Century Cures, value frameworks, medication adherence, and more.
Emphasizing the aim of the conference and ISPOR’s role in facilitating a global dialogue on these issues, ISPOR’s Chief Executive Officer and Executive Director Nancy S. Berg noted, “This year’s meeting focused on bringing evidence and value to healthcare decision making during a time when the healthcare systems in many countries are undergoing significant social and policy changes. ISPOR stands ready to serve as a resource to help inform policy and improve decision making for global healthcare systems.” For additional information, visit www.ispor.org.
